Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever
Abroad (travel likely)Recruiting
Conditions
Leukemia · CART Therapy · Transplantation, Stem Cell · Infections, Bacterial
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Study coordinator (Infectious Diseases Clinical Trials Team) · infectiousdiseases.clinicaltrials@petermac.org · +61448503643Contact: Principal Investigator (Abby Douglas, MBBS PhD FRACP)Royal Melbourne Hospital, Melbourne, Victoria, Australia
Contact: Study coordinator (Infectious Diseases Clinical Trials team) · infectiousdiseases.clinicaltrials@petermac.org · +61448503643Contact: Principal Investigator (Monica A Slavin, MD MBBS PhD FRACP)
Study leads
Abby P Douglas, MBBS PhD FRACP
Principal Investigator
Peter MacCallum Cancer Centre; National Centre for Infections in Cancer